nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Etoposide—germ cell cancer	0.431	1	CbGbCtD
Raltegravir—UGT1A1—urine—germ cell cancer	0.0212	0.129	CbGeAlD
Raltegravir—CCR1—trigeminal ganglion—germ cell cancer	0.0173	0.105	CbGeAlD
Raltegravir—CCR1—decidua—germ cell cancer	0.0129	0.0781	CbGeAlD
Raltegravir—CCR1—uterus—germ cell cancer	0.0112	0.0683	CbGeAlD
Raltegravir—CCR1—pituitary gland—germ cell cancer	0.011	0.0671	CbGeAlD
Raltegravir—CCR1—medulla oblongata—germ cell cancer	0.0107	0.0647	CbGeAlD
Raltegravir—CCR1—adrenal gland—germ cell cancer	0.00986	0.0599	CbGeAlD
Raltegravir—CCR1—midbrain—germ cell cancer	0.00974	0.0592	CbGeAlD
Raltegravir—CCR1—bone marrow—germ cell cancer	0.00954	0.058	CbGeAlD
Raltegravir—CCR1—spinal cord—germ cell cancer	0.0095	0.0577	CbGeAlD
Raltegravir—CCR1—female gonad—germ cell cancer	0.0092	0.0559	CbGeAlD
Raltegravir—CCR1—endocrine gland—germ cell cancer	0.00855	0.052	CbGeAlD
Raltegravir—CCR1—head—germ cell cancer	0.00844	0.0513	CbGeAlD
Raltegravir—CCR1—brain—germ cell cancer	0.00612	0.0372	CbGeAlD
Raltegravir—CCR1—lymph node—germ cell cancer	0.00591	0.0359	CbGeAlD
Raltegravir—UGT1A1—endocrine gland—germ cell cancer	0.00352	0.0214	CbGeAlD
Raltegravir—Confusional state—Bleomycin—germ cell cancer	0.000808	0.002	CcSEcCtD
Raltegravir—Hepatobiliary disease—Etoposide—germ cell cancer	0.000802	0.00198	CcSEcCtD
Raltegravir—Visual impairment—Cisplatin—germ cell cancer	0.000801	0.00198	CcSEcCtD
Raltegravir—Infection—Bleomycin—germ cell cancer	0.000796	0.00197	CcSEcCtD
Raltegravir—Thrombocytopenia—Bleomycin—germ cell cancer	0.000785	0.00194	CcSEcCtD
Raltegravir—Feeling abnormal—Vinblastine—germ cell cancer	0.000782	0.00193	CcSEcCtD
Raltegravir—Myalgia—Dactinomycin—germ cell cancer	0.00078	0.00193	CcSEcCtD
Raltegravir—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000779	0.00193	CcSEcCtD
Raltegravir—Eye disorder—Cisplatin—germ cell cancer	0.000777	0.00192	CcSEcCtD
Raltegravir—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000776	0.00192	CcSEcCtD
Raltegravir—Anaemia—Ifosfamide—germ cell cancer	0.000776	0.00192	CcSEcCtD
Raltegravir—Tinnitus—Cisplatin—germ cell cancer	0.000775	0.00192	CcSEcCtD
Raltegravir—Lymphadenopathy—Methotrexate—germ cell cancer	0.000773	0.00191	CcSEcCtD
Raltegravir—Cardiac disorder—Cisplatin—germ cell cancer	0.000771	0.00191	CcSEcCtD
Raltegravir—Agitation—Ifosfamide—germ cell cancer	0.000771	0.00191	CcSEcCtD
Raltegravir—Discomfort—Dactinomycin—germ cell cancer	0.00077	0.00191	CcSEcCtD
Raltegravir—Diabetes mellitus—Methotrexate—germ cell cancer	0.000758	0.00187	CcSEcCtD
Raltegravir—Hypoaesthesia—Etoposide—germ cell cancer	0.000758	0.00187	CcSEcCtD
Raltegravir—Malaise—Ifosfamide—germ cell cancer	0.000757	0.00187	CcSEcCtD
Raltegravir—Vertigo—Ifosfamide—germ cell cancer	0.000754	0.00187	CcSEcCtD
Raltegravir—Urinary tract disorder—Etoposide—germ cell cancer	0.000752	0.00186	CcSEcCtD
Raltegravir—Immune system disorder—Cisplatin—germ cell cancer	0.000751	0.00186	CcSEcCtD
Raltegravir—Abdominal pain—Vinblastine—germ cell cancer	0.00075	0.00186	CcSEcCtD
Raltegravir—Mediastinal disorder—Cisplatin—germ cell cancer	0.000749	0.00185	CcSEcCtD
Raltegravir—Urethral disorder—Etoposide—germ cell cancer	0.000746	0.00185	CcSEcCtD
Raltegravir—Infection—Dactinomycin—germ cell cancer	0.000742	0.00184	CcSEcCtD
Raltegravir—Palpitations—Ifosfamide—germ cell cancer	0.000742	0.00183	CcSEcCtD
Raltegravir—Alopecia—Cisplatin—germ cell cancer	0.000734	0.00182	CcSEcCtD
Raltegravir—Hepatic failure—Methotrexate—germ cell cancer	0.000734	0.00181	CcSEcCtD
Raltegravir—Cough—Ifosfamide—germ cell cancer	0.000732	0.00181	CcSEcCtD
Raltegravir—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000732	0.00181	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00073	0.00181	CcSEcCtD
Raltegravir—Hypertension—Ifosfamide—germ cell cancer	0.000724	0.00179	CcSEcCtD
Raltegravir—Erythema—Cisplatin—germ cell cancer	0.000723	0.00179	CcSEcCtD
Raltegravir—Malnutrition—Cisplatin—germ cell cancer	0.000723	0.00179	CcSEcCtD
Raltegravir—Erythema multiforme—Etoposide—germ cell cancer	0.00072	0.00178	CcSEcCtD
Raltegravir—Paraesthesia—Bleomycin—germ cell cancer	0.00072	0.00178	CcSEcCtD
Raltegravir—Arthralgia—Ifosfamide—germ cell cancer	0.000714	0.00177	CcSEcCtD
Raltegravir—Chest pain—Ifosfamide—germ cell cancer	0.000714	0.00177	CcSEcCtD
Raltegravir—Myalgia—Ifosfamide—germ cell cancer	0.000714	0.00177	CcSEcCtD
Raltegravir—Flatulence—Cisplatin—germ cell cancer	0.000713	0.00176	CcSEcCtD
Raltegravir—Eye disorder—Etoposide—germ cell cancer	0.000711	0.00176	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000709	0.00176	CcSEcCtD
Raltegravir—Cardiac disorder—Etoposide—germ cell cancer	0.000707	0.00175	CcSEcCtD
Raltegravir—Discomfort—Ifosfamide—germ cell cancer	0.000706	0.00175	CcSEcCtD
Raltegravir—Hypersensitivity—Vinblastine—germ cell cancer	0.000699	0.00173	CcSEcCtD
Raltegravir—Decreased appetite—Bleomycin—germ cell cancer	0.000697	0.00172	CcSEcCtD
Raltegravir—Angiopathy—Etoposide—germ cell cancer	0.000691	0.00171	CcSEcCtD
Raltegravir—Confusional state—Ifosfamide—germ cell cancer	0.000691	0.00171	CcSEcCtD
Raltegravir—Immune system disorder—Etoposide—germ cell cancer	0.000688	0.0017	CcSEcCtD
Raltegravir—Mediastinal disorder—Etoposide—germ cell cancer	0.000686	0.0017	CcSEcCtD
Raltegravir—Pain—Bleomycin—germ cell cancer	0.000685	0.0017	CcSEcCtD
Raltegravir—Chills—Etoposide—germ cell cancer	0.000683	0.00169	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000681	0.00168	CcSEcCtD
Raltegravir—Asthenia—Vinblastine—germ cell cancer	0.000681	0.00168	CcSEcCtD
Raltegravir—Infection—Ifosfamide—germ cell cancer	0.00068	0.00168	CcSEcCtD
Raltegravir—Tremor—Cisplatin—germ cell cancer	0.000678	0.00168	CcSEcCtD
Raltegravir—Alopecia—Etoposide—germ cell cancer	0.000673	0.00166	CcSEcCtD
Raltegravir—Lethargy—Methotrexate—germ cell cancer	0.000673	0.00166	CcSEcCtD
Raltegravir—Nervous system disorder—Ifosfamide—germ cell cancer	0.000672	0.00166	CcSEcCtD
Raltegravir—Ill-defined disorder—Cisplatin—germ cell cancer	0.000671	0.00166	CcSEcCtD
Raltegravir—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000671	0.00166	CcSEcCtD
Raltegravir—Anaemia—Cisplatin—germ cell cancer	0.000669	0.00165	CcSEcCtD
Raltegravir—Skin disorder—Ifosfamide—germ cell cancer	0.000665	0.00165	CcSEcCtD
Raltegravir—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000662	0.00164	CcSEcCtD
Raltegravir—Feeling abnormal—Bleomycin—germ cell cancer	0.00066	0.00163	CcSEcCtD
Raltegravir—Malaise—Cisplatin—germ cell cancer	0.000652	0.00161	CcSEcCtD
Raltegravir—Decreased appetite—Dactinomycin—germ cell cancer	0.00065	0.00161	CcSEcCtD
Raltegravir—Diarrhoea—Vinblastine—germ cell cancer	0.000649	0.00161	CcSEcCtD
Raltegravir—Dysgeusia—Etoposide—germ cell cancer	0.000649	0.00161	CcSEcCtD
Raltegravir—Fatigue—Dactinomycin—germ cell cancer	0.000644	0.00159	CcSEcCtD
Raltegravir—Back pain—Etoposide—germ cell cancer	0.000641	0.00159	CcSEcCtD
Raltegravir—Pain—Dactinomycin—germ cell cancer	0.000639	0.00158	CcSEcCtD
Raltegravir—Urticaria—Bleomycin—germ cell cancer	0.000637	0.00157	CcSEcCtD
Raltegravir—Body temperature increased—Bleomycin—germ cell cancer	0.000633	0.00157	CcSEcCtD
Raltegravir—Dizziness—Vinblastine—germ cell cancer	0.000627	0.00155	CcSEcCtD
Raltegravir—Mood swings—Methotrexate—germ cell cancer	0.000624	0.00154	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000624	0.00154	CcSEcCtD
Raltegravir—Myalgia—Cisplatin—germ cell cancer	0.000616	0.00152	CcSEcCtD
Raltegravir—Feeling abnormal—Dactinomycin—germ cell cancer	0.000616	0.00152	CcSEcCtD
Raltegravir—Paraesthesia—Ifosfamide—germ cell cancer	0.000615	0.00152	CcSEcCtD
Raltegravir—Ill-defined disorder—Etoposide—germ cell cancer	0.000615	0.00152	CcSEcCtD
Raltegravir—Anxiety—Cisplatin—germ cell cancer	0.000614	0.00152	CcSEcCtD
Raltegravir—Anaemia—Etoposide—germ cell cancer	0.000613	0.00152	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000612	0.00151	CcSEcCtD
Raltegravir—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000611	0.00151	CcSEcCtD
Raltegravir—Somnolence—Ifosfamide—germ cell cancer	0.000609	0.00151	CcSEcCtD
Raltegravir—Discomfort—Cisplatin—germ cell cancer	0.000609	0.00151	CcSEcCtD
Raltegravir—Vomiting—Vinblastine—germ cell cancer	0.000603	0.00149	CcSEcCtD
Raltegravir—Malaise—Etoposide—germ cell cancer	0.000598	0.00148	CcSEcCtD
Raltegravir—Breast disorder—Methotrexate—germ cell cancer	0.000596	0.00147	CcSEcCtD
Raltegravir—Vertigo—Etoposide—germ cell cancer	0.000595	0.00147	CcSEcCtD
Raltegravir—Decreased appetite—Ifosfamide—germ cell cancer	0.000595	0.00147	CcSEcCtD
Raltegravir—Headache—Vinblastine—germ cell cancer	0.000594	0.00147	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000591	0.00146	CcSEcCtD
Raltegravir—Abdominal pain—Dactinomycin—germ cell cancer	0.000591	0.00146	CcSEcCtD
Raltegravir—Body temperature increased—Dactinomycin—germ cell cancer	0.000591	0.00146	CcSEcCtD
Raltegravir—Fatigue—Ifosfamide—germ cell cancer	0.00059	0.00146	CcSEcCtD
Raltegravir—Hypersensitivity—Bleomycin—germ cell cancer	0.00059	0.00146	CcSEcCtD
Raltegravir—Infection—Cisplatin—germ cell cancer	0.000587	0.00145	CcSEcCtD
Raltegravir—Constipation—Ifosfamide—germ cell cancer	0.000586	0.00145	CcSEcCtD
Raltegravir—Pain—Ifosfamide—germ cell cancer	0.000586	0.00145	CcSEcCtD
Raltegravir—Nervous system disorder—Cisplatin—germ cell cancer	0.000579	0.00143	CcSEcCtD
Raltegravir—Cough—Etoposide—germ cell cancer	0.000578	0.00143	CcSEcCtD
Raltegravir—Thrombocytopenia—Cisplatin—germ cell cancer	0.000578	0.00143	CcSEcCtD
Raltegravir—Asthenia—Bleomycin—germ cell cancer	0.000575	0.00142	CcSEcCtD
Raltegravir—Skin disorder—Cisplatin—germ cell cancer	0.000573	0.00142	CcSEcCtD
Raltegravir—Hypertension—Etoposide—germ cell cancer	0.000572	0.00142	CcSEcCtD
Raltegravir—Hyperhidrosis—Cisplatin—germ cell cancer	0.000571	0.00141	CcSEcCtD
Raltegravir—Pruritus—Bleomycin—germ cell cancer	0.000567	0.0014	CcSEcCtD
Raltegravir—Feeling abnormal—Ifosfamide—germ cell cancer	0.000564	0.0014	CcSEcCtD
Raltegravir—Chest pain—Etoposide—germ cell cancer	0.000564	0.0014	CcSEcCtD
Raltegravir—Eosinophilia—Methotrexate—germ cell cancer	0.000564	0.0014	CcSEcCtD
Raltegravir—Nausea—Vinblastine—germ cell cancer	0.000564	0.00139	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00056	0.00139	CcSEcCtD
Raltegravir—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00056	0.00139	CcSEcCtD
Raltegravir—Discomfort—Etoposide—germ cell cancer	0.000557	0.00138	CcSEcCtD
Raltegravir—Hypersensitivity—Dactinomycin—germ cell cancer	0.000551	0.00136	CcSEcCtD
Raltegravir—Abdominal discomfort—Methotrexate—germ cell cancer	0.000546	0.00135	CcSEcCtD
Raltegravir—Confusional state—Etoposide—germ cell cancer	0.000545	0.00135	CcSEcCtD
Raltegravir—Urticaria—Ifosfamide—germ cell cancer	0.000544	0.00135	CcSEcCtD
Raltegravir—Body temperature increased—Ifosfamide—germ cell cancer	0.000541	0.00134	CcSEcCtD
Raltegravir—Abdominal pain—Ifosfamide—germ cell cancer	0.000541	0.00134	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000538	0.00133	CcSEcCtD
Raltegravir—Infection—Etoposide—germ cell cancer	0.000537	0.00133	CcSEcCtD
Raltegravir—Asthenia—Dactinomycin—germ cell cancer	0.000536	0.00133	CcSEcCtD
Raltegravir—Neutropenia—Methotrexate—germ cell cancer	0.000533	0.00132	CcSEcCtD
Raltegravir—Paraesthesia—Cisplatin—germ cell cancer	0.00053	0.00131	CcSEcCtD
Raltegravir—Thrombocytopenia—Etoposide—germ cell cancer	0.00053	0.00131	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00053	0.00131	CcSEcCtD
Raltegravir—Skin disorder—Etoposide—germ cell cancer	0.000525	0.0013	CcSEcCtD
Raltegravir—Erectile dysfunction—Methotrexate—germ cell cancer	0.000525	0.0013	CcSEcCtD
Raltegravir—Hyperhidrosis—Etoposide—germ cell cancer	0.000523	0.00129	CcSEcCtD
Raltegravir—Decreased appetite—Cisplatin—germ cell cancer	0.000513	0.00127	CcSEcCtD
Raltegravir—Diarrhoea—Dactinomycin—germ cell cancer	0.000511	0.00126	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00051	0.00126	CcSEcCtD
Raltegravir—Vomiting—Bleomycin—germ cell cancer	0.00051	0.00126	CcSEcCtD
Raltegravir—Infestation NOS—Methotrexate—germ cell cancer	0.000508	0.00126	CcSEcCtD
Raltegravir—Infestation—Methotrexate—germ cell cancer	0.000508	0.00126	CcSEcCtD
Raltegravir—Depression—Methotrexate—germ cell cancer	0.000507	0.00125	CcSEcCtD
Raltegravir—Rash—Bleomycin—germ cell cancer	0.000505	0.00125	CcSEcCtD
Raltegravir—Pain—Cisplatin—germ cell cancer	0.000505	0.00125	CcSEcCtD
Raltegravir—Dermatitis—Bleomycin—germ cell cancer	0.000505	0.00125	CcSEcCtD
Raltegravir—Hypersensitivity—Ifosfamide—germ cell cancer	0.000505	0.00125	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000504	0.00125	CcSEcCtD
Raltegravir—Renal failure—Methotrexate—germ cell cancer	0.000499	0.00124	CcSEcCtD
Raltegravir—Asthenia—Ifosfamide—germ cell cancer	0.000491	0.00122	CcSEcCtD
Raltegravir—Feeling abnormal—Cisplatin—germ cell cancer	0.000487	0.0012	CcSEcCtD
Raltegravir—Paraesthesia—Etoposide—germ cell cancer	0.000486	0.0012	CcSEcCtD
Raltegravir—Pruritus—Ifosfamide—germ cell cancer	0.000485	0.0012	CcSEcCtD
Raltegravir—Haematuria—Methotrexate—germ cell cancer	0.000484	0.0012	CcSEcCtD
Raltegravir—Somnolence—Etoposide—germ cell cancer	0.000481	0.00119	CcSEcCtD
Raltegravir—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00048	0.00119	CcSEcCtD
Raltegravir—Epistaxis—Methotrexate—germ cell cancer	0.000479	0.00119	CcSEcCtD
Raltegravir—Nausea—Bleomycin—germ cell cancer	0.000476	0.00118	CcSEcCtD
Raltegravir—Vomiting—Dactinomycin—germ cell cancer	0.000475	0.00118	CcSEcCtD
Raltegravir—Rash—Dactinomycin—germ cell cancer	0.000471	0.00117	CcSEcCtD
Raltegravir—Decreased appetite—Etoposide—germ cell cancer	0.00047	0.00116	CcSEcCtD
Raltegravir—Diarrhoea—Ifosfamide—germ cell cancer	0.000469	0.00116	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000467	0.00116	CcSEcCtD
Raltegravir—Body temperature increased—Cisplatin—germ cell cancer	0.000467	0.00115	CcSEcCtD
Raltegravir—Fatigue—Etoposide—germ cell cancer	0.000466	0.00115	CcSEcCtD
Raltegravir—Pain—Etoposide—germ cell cancer	0.000463	0.00114	CcSEcCtD
Raltegravir—Constipation—Etoposide—germ cell cancer	0.000463	0.00114	CcSEcCtD
Raltegravir—Hepatitis—Methotrexate—germ cell cancer	0.000456	0.00113	CcSEcCtD
Raltegravir—Dizziness—Ifosfamide—germ cell cancer	0.000453	0.00112	CcSEcCtD
Raltegravir—Urinary tract disorder—Methotrexate—germ cell cancer	0.00045	0.00111	CcSEcCtD
Raltegravir—Urethral disorder—Methotrexate—germ cell cancer	0.000447	0.00111	CcSEcCtD
Raltegravir—Feeling abnormal—Etoposide—germ cell cancer	0.000446	0.0011	CcSEcCtD
Raltegravir—Nausea—Dactinomycin—germ cell cancer	0.000444	0.0011	CcSEcCtD
Raltegravir—Gastrointestinal pain—Etoposide—germ cell cancer	0.000442	0.00109	CcSEcCtD
Raltegravir—Visual impairment—Methotrexate—germ cell cancer	0.000439	0.00109	CcSEcCtD
Raltegravir—Vomiting—Ifosfamide—germ cell cancer	0.000435	0.00108	CcSEcCtD
Raltegravir—Hypersensitivity—Cisplatin—germ cell cancer	0.000435	0.00108	CcSEcCtD
Raltegravir—Rash—Ifosfamide—germ cell cancer	0.000432	0.00107	CcSEcCtD
Raltegravir—Dermatitis—Ifosfamide—germ cell cancer	0.000431	0.00107	CcSEcCtD
Raltegravir—Erythema multiforme—Methotrexate—germ cell cancer	0.000431	0.00107	CcSEcCtD
Raltegravir—Urticaria—Etoposide—germ cell cancer	0.00043	0.00106	CcSEcCtD
Raltegravir—Abdominal pain—Etoposide—germ cell cancer	0.000428	0.00106	CcSEcCtD
Raltegravir—Body temperature increased—Etoposide—germ cell cancer	0.000428	0.00106	CcSEcCtD
Raltegravir—Eye disorder—Methotrexate—germ cell cancer	0.000426	0.00105	CcSEcCtD
Raltegravir—Tinnitus—Methotrexate—germ cell cancer	0.000425	0.00105	CcSEcCtD
Raltegravir—Asthenia—Cisplatin—germ cell cancer	0.000424	0.00105	CcSEcCtD
Raltegravir—Cardiac disorder—Methotrexate—germ cell cancer	0.000423	0.00105	CcSEcCtD
Raltegravir—Angiopathy—Methotrexate—germ cell cancer	0.000414	0.00102	CcSEcCtD
Raltegravir—Immune system disorder—Methotrexate—germ cell cancer	0.000412	0.00102	CcSEcCtD
Raltegravir—Mediastinal disorder—Methotrexate—germ cell cancer	0.000411	0.00102	CcSEcCtD
Raltegravir—Chills—Methotrexate—germ cell cancer	0.000409	0.00101	CcSEcCtD
Raltegravir—Nausea—Ifosfamide—germ cell cancer	0.000407	0.00101	CcSEcCtD
Raltegravir—Diarrhoea—Cisplatin—germ cell cancer	0.000404	0.000999	CcSEcCtD
Raltegravir—Alopecia—Methotrexate—germ cell cancer	0.000403	0.000997	CcSEcCtD
Raltegravir—Mental disorder—Methotrexate—germ cell cancer	0.0004	0.000988	CcSEcCtD
Raltegravir—Hypersensitivity—Etoposide—germ cell cancer	0.000399	0.000986	CcSEcCtD
Raltegravir—Erythema—Methotrexate—germ cell cancer	0.000397	0.000982	CcSEcCtD
Raltegravir—Malnutrition—Methotrexate—germ cell cancer	0.000397	0.000982	CcSEcCtD
Raltegravir—Dysgeusia—Methotrexate—germ cell cancer	0.000389	0.000962	CcSEcCtD
Raltegravir—Asthenia—Etoposide—germ cell cancer	0.000388	0.00096	CcSEcCtD
Raltegravir—Back pain—Methotrexate—germ cell cancer	0.000384	0.00095	CcSEcCtD
Raltegravir—Pruritus—Etoposide—germ cell cancer	0.000383	0.000947	CcSEcCtD
Raltegravir—Vomiting—Cisplatin—germ cell cancer	0.000375	0.000929	CcSEcCtD
Raltegravir—Rash—Cisplatin—germ cell cancer	0.000372	0.000921	CcSEcCtD
Raltegravir—Dermatitis—Cisplatin—germ cell cancer	0.000372	0.00092	CcSEcCtD
Raltegravir—Diarrhoea—Etoposide—germ cell cancer	0.00037	0.000916	CcSEcCtD
Raltegravir—Ill-defined disorder—Methotrexate—germ cell cancer	0.000368	0.000911	CcSEcCtD
Raltegravir—Anaemia—Methotrexate—germ cell cancer	0.000367	0.000908	CcSEcCtD
Raltegravir—Malaise—Methotrexate—germ cell cancer	0.000358	0.000886	CcSEcCtD
Raltegravir—Dizziness—Etoposide—germ cell cancer	0.000358	0.000885	CcSEcCtD
Raltegravir—Vertigo—Methotrexate—germ cell cancer	0.000357	0.000882	CcSEcCtD
Raltegravir—Nausea—Cisplatin—germ cell cancer	0.000351	0.000868	CcSEcCtD
Raltegravir—Cough—Methotrexate—germ cell cancer	0.000346	0.000857	CcSEcCtD
Raltegravir—Vomiting—Etoposide—germ cell cancer	0.000344	0.000851	CcSEcCtD
Raltegravir—Rash—Etoposide—germ cell cancer	0.000341	0.000844	CcSEcCtD
Raltegravir—Dermatitis—Etoposide—germ cell cancer	0.000341	0.000843	CcSEcCtD
Raltegravir—Headache—Etoposide—germ cell cancer	0.000339	0.000838	CcSEcCtD
Raltegravir—Arthralgia—Methotrexate—germ cell cancer	0.000338	0.000836	CcSEcCtD
Raltegravir—Chest pain—Methotrexate—germ cell cancer	0.000338	0.000836	CcSEcCtD
Raltegravir—Myalgia—Methotrexate—germ cell cancer	0.000338	0.000836	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000336	0.00083	CcSEcCtD
Raltegravir—Discomfort—Methotrexate—germ cell cancer	0.000334	0.000826	CcSEcCtD
Raltegravir—Confusional state—Methotrexate—germ cell cancer	0.000327	0.000808	CcSEcCtD
Raltegravir—Infection—Methotrexate—germ cell cancer	0.000322	0.000796	CcSEcCtD
Raltegravir—Nausea—Etoposide—germ cell cancer	0.000321	0.000795	CcSEcCtD
Raltegravir—Nervous system disorder—Methotrexate—germ cell cancer	0.000318	0.000786	CcSEcCtD
Raltegravir—Thrombocytopenia—Methotrexate—germ cell cancer	0.000317	0.000785	CcSEcCtD
Raltegravir—Skin disorder—Methotrexate—germ cell cancer	0.000315	0.000778	CcSEcCtD
Raltegravir—Hyperhidrosis—Methotrexate—germ cell cancer	0.000313	0.000775	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000295	0.00073	CcSEcCtD
Raltegravir—Insomnia—Methotrexate—germ cell cancer	0.000293	0.000725	CcSEcCtD
Raltegravir—Paraesthesia—Methotrexate—germ cell cancer	0.000291	0.00072	CcSEcCtD
Raltegravir—Somnolence—Methotrexate—germ cell cancer	0.000288	0.000713	CcSEcCtD
Raltegravir—Dyspepsia—Methotrexate—germ cell cancer	0.000285	0.000706	CcSEcCtD
Raltegravir—Decreased appetite—Methotrexate—germ cell cancer	0.000282	0.000697	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00028	0.000692	CcSEcCtD
Raltegravir—Fatigue—Methotrexate—germ cell cancer	0.000279	0.000691	CcSEcCtD
Raltegravir—Pain—Methotrexate—germ cell cancer	0.000277	0.000685	CcSEcCtD
Raltegravir—Feeling abnormal—Methotrexate—germ cell cancer	0.000267	0.00066	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000265	0.000655	CcSEcCtD
Raltegravir—Urticaria—Methotrexate—germ cell cancer	0.000257	0.000637	CcSEcCtD
Raltegravir—Body temperature increased—Methotrexate—germ cell cancer	0.000256	0.000634	CcSEcCtD
Raltegravir—Abdominal pain—Methotrexate—germ cell cancer	0.000256	0.000634	CcSEcCtD
Raltegravir—Hypersensitivity—Methotrexate—germ cell cancer	0.000239	0.00059	CcSEcCtD
Raltegravir—Asthenia—Methotrexate—germ cell cancer	0.000232	0.000575	CcSEcCtD
Raltegravir—Pruritus—Methotrexate—germ cell cancer	0.000229	0.000567	CcSEcCtD
Raltegravir—Diarrhoea—Methotrexate—germ cell cancer	0.000222	0.000548	CcSEcCtD
Raltegravir—Dizziness—Methotrexate—germ cell cancer	0.000214	0.00053	CcSEcCtD
Raltegravir—Vomiting—Methotrexate—germ cell cancer	0.000206	0.00051	CcSEcCtD
Raltegravir—Rash—Methotrexate—germ cell cancer	0.000204	0.000505	CcSEcCtD
Raltegravir—Dermatitis—Methotrexate—germ cell cancer	0.000204	0.000505	CcSEcCtD
Raltegravir—Headache—Methotrexate—germ cell cancer	0.000203	0.000502	CcSEcCtD
Raltegravir—Nausea—Methotrexate—germ cell cancer	0.000192	0.000476	CcSEcCtD
